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Characterization of Pathogenicity, Virulence and Host-Pathogen Interactions
The threats of bio-terrorism and newly emerging infectious diseases pose serious challenges 
to the national security infrastructure. Rapid detection and diagnosis of infectious disease in 
human populations, as well as characterizing pathogen biology, are critical for reducing the 
morbidity and mortality associated with such threats. One of the key challenges in managing 
an infectious disease outbreak, whether through natural causes or acts of overt terrorism, is 
detection early enough to initiate effective countermeasures. Much recent attention has been 
directed towards the utility of biomarkers or molecular signatures that result from the 
interaction of the pathogen with the host for improving our ability to diagnose and mitigate the 
impact of a developing infection during the time window when effective countermeasures can 
be instituted.  Host responses may provide early signals in blood even from localized 
infections.  Multiple innate and adaptive immune molecules, in combination with other 
biochemical markers, may provide disease-specific information and new targets for 
countermeasures. The presence of pathogen specific markers and an understanding of the 
molecular capabilities and adaptations of the pathogen when it interacts with its host may 
likewise assist in early detection and provide opportunities for targeting countermeasures.  An 
important question that needs to be addressed is whether these molecular-based approaches 
will prove useful for early diagnosis, complement current methods of direct agent detection, 
and aid development and use of countermeasures. 
Lawrence Livermore National Laboratory (LLNL) will host a workshop to explore the utility of 
host- and pathogen-based molecular diagnostics, prioritize key research issues, and 
determine the critical steps needed to transition host-pathogen research to tools that can be 
applied towards a more effective national bio-defense strategy. The workshop will bring 
together leading researchers/scientists in the area of host-pathogen interactions as well as 
policy makers from federal agencies.  The main objectives of the workshop are:
• to assess the current national needs, capabilities, near-term technologies, and future 
challenges in applying various diagnostics tools to public health and bio-defense
• to evaluate the utility and feasibility of host-response and pathogen biomarker profiling 
in the diagnosis and management of infectious diseases
• to create a comprehensive developmental strategy from proof-of-concept, through 
validation, to deployment of  appropriate advanced technology for the clinical/public 
health and bio-defense environments
The workshop will be a 2-day event (to be held at Livermore, CA) scheduled for September 13 
and 14, 2006.  An additional day (September 15) will be reserved for laboratory tours and site 
visits.  
LLNL has a long history of successfully developing and deploying technologies and systems 
for rapid detection and identification of biological pathogens in support of national security.  
Additionally, LLNL has unique resources such as the High Performance Computing Center
(HPCC), Center for Accelerator Mass Spectrometry (CAMS), Livermore Micro-Array Center 
(LMAC), National Atmospheric Release Advisory Center (NARAC) and a range of other infra-
structure capabilities to support development, testing and evaluation of technologies/systems 
for bio-defense applications.  LLNL is committed to researching and continuing to develop the 
next-generation tools for diagnosis and mitigation of the risk from both emerging infectious 
diseases and threats from bioterrorism.
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Sept. 13-15, 2006 ; LLNL- B543 Auditorium
Wednesday, September 13, 2006 (8:00 AM – 5:00 PM)
Session 1 : Role of Host-Pathogen Science in Public Health & Bio-Defense
• Talks by speakers from HHS, CDC, NIH, DHS + Leading academics : Key 
issues facing bio-defense and public health, emerging/unknown/engineered 
(EUE) pathogens 
• Discussion of public preparedness, current state-of-the-art, future 
requirements and priorities for bio-defense, challenges to be addressed, …
Session 2 : Mechanisms of  pathogen virulence and host immune evasion
• Viral/Bacterial/fungal mechanisms of pathogenesis
• Zoonoses and animal models
• Key pathogens and appropriate model systems
• Bio-defense issues/relevance, EUE pathogens
• Panel Discussion
Thursday, September 14, 2006 (8:00 AM – 5:00 PM) 
Session 3 : Mechanisms of host response
• Innate and cellular response to pathogens (bio-markers, signatures of 
infections)
• Animal models and relevance to human studies
• Technologies for diagnosis of infections
• Bio-defense issues & relevance, EUE pathogens
• Panel Discussion
Session 4 : Applications to bio-defense (Detection, diagnosis, mitigation)
• Applications to detection, diagnosis, public response & containment
• Novel therapeutic strategies & technologies for detection & diagnosis
• Discussion of above in the context of emerging pathogens (i.e., bird flu) & 
bio-threats
• Panel Discussion
Friday, September 15, 2006 
Lab Tours/Demos for External Attendees : TSF, CAMS, NARAC, BAMS, Bio-Briefcase
